Anticoagulants: Monitoring And Bleeding Precautions - NCLEX Rn

1. Which over-the-counter medication should be avoided unless prescribed due to increased bleeding risk with anticoagulants?

   Aspirin or NSAIDs (e.g., ibuprofen, naproxen). These inhibit platelet function, synergistically increasing bleeding risk when combined with anticoagulants.

2. Which anticoagulant class generally does not require routine PT/INR or aPTT monitoring in stable patients?

   DOACs (e.g., apixaban, rivaroxaban, dabigatran). These agents have predictable pharmacokinetics, eliminating the need for routine lab monitoring in patients with stable renal function.

3. What is the preferred needle size range to reduce tissue trauma when injections are unavoidable in anticoagulated patients?

   Small-gauge needle (about $22$ to $25$ gauge). Smaller gauges cause less vessel trauma, reducing the likelihood of prolonged bleeding or hematoma formation.

4. What dietary teaching is essential for a patient taking warfarin regarding vitamin K intake?

   Keep vitamin K intake consistent; do not make sudden changes. Consistent intake maintains stable INR levels, as vitamin K antagonizes warfarin's effect on clotting factors.

5. What is the typical therapeutic aPTT goal for IV unfractionated heparin?

   About $1.5$ to $2.5\times$ the control value. This range indicates effective inhibition of clotting factors while minimizing hemorrhage risk, based on established guidelines for heparin therapy.

6. Which lab tests are most important to monitor for bleeding risk with DOAC therapy over time?

   Renal function (Cr/CrCl) and CBC (Hgb/Hct, platelets). DOACs are renally cleared, so monitoring creatinine clearance prevents accumulation, while CBC detects anemia or thrombocytopenia indicating bleeding.

7. What laboratory test is primarily used to monitor IV unfractionated heparin therapy?

   aPTT (or anti-Xa per facility protocol). aPTT measures the intrinsic pathway and is prolonged by heparin, making it the standard for adjusting IV doses to ensure therapeutic anticoagulation without excessive bleeding risk.

8. Identify the immediate nursing action when HIT is suspected in a patient receiving heparin.

   Stop all heparin immediately and notify the provider. Immediate cessation prevents further platelet activation and thrombotic complications, with provider notification ensuring alternative anticoagulation.

9. What specific reversal agent is used for factor Xa inhibitors such as apixaban and rivaroxaban?

   Andexanet alfa. This recombinant factor Xa decoy binds inhibitors, reversing their anticoagulant effects in major bleeding events.

10. Which oral care item is safest to reduce mucosal bleeding risk while on anticoagulants?

    Soft-bristled toothbrush. Soft bristles minimize gingival trauma, decreasing the risk of oral bleeding in patients with coagulopathy.

11. Which injection route should be avoided when possible in patients receiving therapeutic anticoagulation?

    Intramuscular injections. IM injections can cause large hematomas because the needle enters muscle, where bleeding is hard to see or compress when clotting is impaired.

12. Which stool or urine finding is a red flag for bleeding in a patient on anticoagulants?

    Melena or hematuria. These indicate gastrointestinal or genitourinary bleeding, common sites for anticoagulant-related hemorrhage due to impaired clotting.

13. What laboratory test is used to monitor warfarin therapy?

    PT/INR. Warfarin inhibits vitamin K-dependent clotting factors, prolonging PT and INR, which are used to assess therapeutic efficacy and adjust dosing.

14. What antidote reverses unfractionated heparin anticoagulation?

    Protamine sulfate. It binds to heparin, neutralizing its anticoagulant effect rapidly in cases of overdose or severe bleeding.

15. Which safety precaution should be implemented in the inpatient setting for a patient on anticoagulants to reduce trauma-related bleeding?

    Implement fall precautions and minimize injury risk. Falls can cause trauma-induced bleeding, so precautions like bed alarms and assistance minimize injury in vulnerable patients.

16. What specific reversal agent is used for dabigatran (a direct thrombin inhibitor)?

    Idarucizumab. As a monoclonal antibody fragment, it specifically binds and neutralizes dabigatran, restoring hemostasis in life-threatening bleeds.

17. What neurologic symptom should be treated as possible intracranial hemorrhage in a patient on anticoagulants?

    Sudden severe headache or acute neurologic deficit. Such symptoms may signal intracranial bleeding, a life-threatening complication requiring immediate imaging and reversal.

18. Which shaving method is recommended to reduce bleeding risk in patients taking anticoagulants?

    Electric razor. Electric razors reduce nicks and cuts compared to blades, lowering the chance of uncontrolled bleeding.

19. Identify the correct action if a patient on warfarin reports new black, tarry stools.

    Hold the dose and notify the provider immediately. Black tarry stools suggest GI bleeding, necessitating dose withholding and provider assessment to prevent further hemorrhage.

20. What is the priority assessment finding that indicates possible internal bleeding in an anticoagulated patient?

    New hypotension with tachycardia (possible hemorrhage). These vital sign changes suggest hypovolemic shock from occult blood loss, requiring urgent intervention in anticoagulated patients.

21. What is the correct technique after venipuncture or injection in an anticoagulated patient to reduce bleeding?

    Apply firm pressure for a prolonged time; do not rub. Firm pressure promotes hemostasis without disrupting clot formation, while avoiding rubbing prevents dislodging nascent clots.

22. What antidote is used for warfarin-associated bleeding or urgent reversal?

    Vitamin K (phytonadione); PCC for urgent reversal per orders. Vitamin K restores clotting factor synthesis, while PCC provides concentrated factors for faster reversal in emergencies.

23. Which lab value is most important to check before initiating heparin therapy to assess baseline bleeding risk?

    Platelet count (baseline). Establishing a baseline platelet count allows monitoring for thrombocytopenia, a key indicator of heparin-induced complications or bleeding predisposition.

24. What is the most common therapeutic INR range for warfarin in many indications?

    INR $2.0$ to $3.0$. This range balances thromboembolism prevention with bleeding risk for conditions like atrial fibrillation or DVT, per clinical guidelines.

25. What platelet trend should make you suspect heparin-induced thrombocytopenia (HIT)?

    Platelets fall by $\geq 50\%$ from baseline. A significant drop signals potential immune-mediated platelet destruction in HIT, requiring prompt intervention to prevent thrombosis.

Study these flashcards